C000000432 Holdings — Invesco V.I. Health Care Fund
All 82 reported holdings of Invesco V.I. Health Care Fund (C000000432) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly and Co. | 9.14% | $13.57M |
| Johnson & Johnson | 5.81% | $8.63M |
| AstraZeneca PLC | 4.36% | $6.47M |
| Gilead Sciences, Inc. | 4.12% | $6.11M |
| AbbVie Inc. | 3.72% | $5.52M |
| Cencora, Inc. | 3.65% | $5.42M |
| McKesson Corp. | 3.61% | $5.35M |
| argenx SE | 3.39% | $5.03M |
| Invesco Private Prime Fund | 2.89% | $4.28M |
| Invesco Treasury Portfolio | 2.48% | $3.68M |
| Merck & Co., Inc. | 2.27% | $3.36M |
| Welltower Inc. | 2.09% | $3.10M |
| HCA Healthcare, Inc. | 2.05% | $3.04M |
| Vertex Pharmaceuticals Inc. | 1.99% | $2.96M |
| Royalty Pharma PLC | 1.85% | $2.75M |
| BrightSpring Health Services, Inc. | 1.80% | $2.67M |
| Insmed Inc. | 1.73% | $2.56M |
| Cardinal Health, Inc. | 1.68% | $2.50M |
| Regeneron Pharmaceuticals, Inc. | 1.68% | $2.49M |
| Thermo Fisher Scientific Inc. | 1.56% | $2.32M |
| U C B S.a. | 1.54% | $2.28M |
| Guardant Health, Inc. | 1.54% | $2.28M |
| Natera, Inc. | 1.51% | $2.24M |
| IDEXX Laboratories, Inc. | 1.44% | $2.13M |
| BridgeBio Pharma, Inc. | 1.41% | $2.09M |
| UnitedHealth Group Inc. | 1.41% | $2.09M |
| Axsome Therapeutics, Inc. | 1.30% | $1.93M |
| Invesco Government & Agency Portfolio | 1.29% | $1.92M |
| Intuitive Surgical, Inc. | 1.23% | $1.83M |
| United Therapeutics Corp. | 1.20% | $1.78M |
| Sandoz Group AG | 1.16% | $1.72M |
| Mettler-Toledo International Inc. | 1.16% | $1.72M |
| Edwards Lifesciences Corp. | 1.12% | $1.66M |
| Invesco Private Government Fund | 1.11% | $1.65M |
| Boston Scientific Corp. | 1.11% | $1.64M |
| Ascendis Pharma A/S | 1.09% | $1.62M |
| Tenet Healthcare Corp. | 1.08% | $1.61M |
| Encompass Health Corp. | 1.00% | $1.48M |
| Madrigal Pharmaceuticals, Inc. | 0.97% | $1.44M |
| Protagonist Therapeutics, Inc. | 0.96% | $1.43M |
| CVS Health Corp. | 0.96% | $1.42M |
| Medline Inc. | 0.88% | $1.31M |
| Halozyme Therapeutics, Inc. | 0.88% | $1.30M |
| Galderma Group AG | 0.86% | $1.27M |
| Lonza Group AG | 0.83% | $1.23M |
| Ligand Pharmaceuticals Inc. | 0.80% | $1.19M |
| Ionis Pharmaceuticals, Inc. | 0.71% | $1.05M |
| Globus Medical, Inc. | 0.66% | $981.79K |
| Steris PLC | 0.64% | $952.85K |
| Labcorp Holdings Inc. | 0.64% | $945.57K |
| Quest Diagnostics Inc. | 0.62% | $915.42K |
| Medpace Holdings, Inc. | 0.52% | $775.99K |
| Alignment Healthcare, Inc. | 0.48% | $708.71K |
| Tarsus Pharmaceuticals, Inc. | 0.48% | $706.69K |
| Stryker Corp. | 0.47% | $696.94K |
| LeMaitre Vascular, Inc. | 0.42% | $625.54K |
| Alnylam Pharmaceuticals, Inc. | 0.39% | $576.04K |
| BeOne Medicines Ltd. | 0.34% | $500.39K |
| Repligen Corp. | 0.33% | $492.84K |
| IRhythm Holdings, Inc. | 0.33% | $492.73K |
| Arrowhead Pharmaceuticals, Inc. | 0.33% | $485.11K |
| Twist Bioscience Corp. | 0.31% | $461.04K |
| Rapport Therapeutics, Inc. | 0.30% | $447.70K |
| Nuvalent, Inc. | 0.30% | $443.10K |
| RadNet, Inc. | 0.30% | $439.85K |
| Revolution Medicines, Inc. | 0.29% | $437.14K |
| TransMedics Group, Inc. | 0.29% | $434.52K |
| GeneDx Holdings Corp. | 0.29% | $423.92K |
| Cytokinetics, Inc. | 0.28% | $412.60K |
| Heartflow, Inc. | 0.26% | $383.59K |
| BioLife Solutions, Inc. | 0.25% | $376.49K |
| Cogent Biosciences, Inc. | 0.25% | $371.89K |
| Dianthus Therapeutics, Inc. | 0.25% | $365.98K |
| Rhythm Pharmaceuticals, Inc. | 0.23% | $347.18K |
| Palvella Therapeutics, Inc. | 0.23% | $335.43K |
| HealthEquity, Inc. | 0.21% | $312.64K |
| Bio-Techne Corp. | 0.20% | $304.31K |
| Phathom Pharmaceuticals, Inc. | 0.18% | $267.30K |
| Caris Life Sciences, Inc. | 0.17% | $257.02K |
| Mirum Pharmaceuticals, Inc. | 0.15% | $223.93K |
| Charles River Laboratories International, Inc. | 0.11% | $166.29K |
| BillionToOne, Inc. | 0.10% | $151.64K |
C000000432 overview: performance, fees, allocation and SEC filings